Literature DB >> 9466423

Neuronal histamine deficit in Alzheimer's disease.

P Panula1, J Rinne, K Kuokkanen, K S Eriksson, T Sallmen, H Kalimo, M Relja.   

Abstract

Histamine is known to be a neurotransmitter in the brain, but it has not been clearly implicated in major diseases. All histaminergic neurons reside in the posterior hypothalamus and innervate most brain areas, which is compatible with the concept that histamine is involved in general central regulatory mechanisms. A sensitive high-performance liquid chromatographic fluorimetric method was used to measure histamine contents in post mortem Alzheimer brains and age-matched controls. The cellular storage sites and distribution of histaminergic nerve fibers were examined with a specific immunohistochemical method. The histamine content was significantly reduced in the hypothalamus (42% of control value), hippocampus (43%) and temporal cortex (53%) of Alzheimer brains. Differences in other cortical areas, putamen and substantia nigra were not significant. Histamine-containing nerve fibers were found in the hippocampus, parahippocampal gyrus and subiculum of both Alzheimer brains and controls. No histamine-containing mast cells were seen in these temporal structures. Histamine in the human temporal lobe is stored in nerve fibers originating from the posterior hypothalamus, and not in mast cells. Decrease in brain histamine may contribute to the cognitive decline in Alzheimer's disease directly or through the cholinergic system. Development of drugs that penetrate the blood brain barrier and increase histaminergic activity might be beneficial in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466423     DOI: 10.1016/s0306-4522(97)00353-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  30 in total

1.  Neurometabolic roles of ApoE and Ldl-R in mouse brain.

Authors:  Jieun Lee; Joseph Choi; G William Wong; Michael J Wolfgang
Journal:  J Bioenerg Biomembr       Date:  2015-12-21       Impact factor: 2.945

2.  Carnosine protects against Abeta42-induced neurotoxicity in differentiated rat PC12 cells.

Authors:  Qiuli Fu; Haibin Dai; Weiwei Hu; Yanying Fan; Yao Shen; Weiping Zhang; Zhong Chen
Journal:  Cell Mol Neurobiol       Date:  2007-11-20       Impact factor: 5.046

Review 3.  The histamine H3 receptor: an attractive target for the treatment of cognitive disorders.

Authors:  T A Esbenshade; K E Browman; R S Bitner; M Strakhova; M D Cowart; J D Brioni
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

Review 4.  Therapeutics of Neurotransmitters in Alzheimer's Disease.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodic memory.

Authors:  P van Ruitenbeek; A Vermeeren; W J Riedel
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

6.  Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease.

Authors:  Ranjana Patnaik; Aruna Sharma; Stephen D Skaper; Dafin F Muresanu; José Vicente Lafuente; Rudy J Castellani; Ala Nozari; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

7.  Histamine innervation and activation of septohippocampal GABAergic neurones: involvement of local ACh release.

Authors:  Changqing Xu; Kimmo A Michelsen; Min Wu; Elena Morozova; Pertti Panula; Meenakshi Alreja
Journal:  J Physiol       Date:  2004-10-14       Impact factor: 5.182

8.  Histamine is required for H₃ receptor-mediated alcohol reward inhibition, but not for alcohol consumption or stimulation.

Authors:  J Vanhanen; S Nuutinen; M Lintunen; T Mäki; J Rämö; K Karlstedt; P Panula
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

9.  Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice.

Authors:  A D Medhurst; J C Roberts; J Lee; C P L-H Chen; S H Brown; S Roman; M K P Lai
Journal:  Br J Pharmacol       Date:  2009-02-16       Impact factor: 8.739

10.  Identification of inhibitors of Plasmodium falciparum phosphoethanolamine methyltransferase using an enzyme-coupled transmethylation assay.

Authors:  April M Bobenchik; Jae-Yeon Choi; Arunima Mishra; Iulian N Rujan; Bing Hao; Dennis R Voelker; Jeffrey C Hoch; Choukri Ben Mamoun
Journal:  BMC Biochem       Date:  2010-01-19       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.